Nationwide Fund Advisors Eagle Pharmaceuticals, Inc. Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$49.6 - $60.87 $227,118 - $278,723	-4,579 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$46.62 - $60.36 $10,722 - $13,882	-230 Reduced 4.78%	4,579 $273,000
Q2 2017 Aug 10, 2017	BUY	N/A	4,809	4,809 $379,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.